Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Single-center, Real-world Experience of Chronic GVHD Treatment Using Ibrutinib, Imatinib, and Ruxolitinib and its Treatment Outcomes.
Linn SM, Novitzky-Basso I, Abduljalil O, Pasic I, Lam W, Law A, Michelis FV, Gerbitz A, Viswabandya A, Lipton J, Kumar R, Mattsson J, Kim DDH. Linn SM, et al. Among authors: pasic i. Hematol Oncol Stem Cell Ther. 2023 Jul 20;17(1):60-71. doi: 10.56875/2589-0646.1111. Hematol Oncol Stem Cell Ther. 2023. PMID: 37581458 Free article.
Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation.
Pasic I, Lipton JH, Kim DD, Viswabandya A, Kumar R, Lam W, Law AD, Mattsson J, Michelis FV. Pasic I, et al. Ann Hematol. 2020 Jun;99(6):1377-1387. doi: 10.1007/s00277-020-04033-2. Epub 2020 May 7. Ann Hematol. 2020. PMID: 32382774
Less Is More: Superior Graft-versus-Host Disease-Free/Relapse-Free Survival with Reduced-Intensity Conditioning and Dual T Cell Depletion in Acute Myelogenous Leukemia.
Salas MQ, Chen S, Lam W, Pasic I, Gerbitz A, Michelis FV, Kim DDH, Al-Shaibani Z, Lipton JH, Mattsson J, Kumar R, Viswabandya A, Law AD. Salas MQ, et al. Among authors: pasic i. Biol Blood Marrow Transplant. 2020 Aug;26(8):1511-1519. doi: 10.1016/j.bbmt.2020.04.021. Epub 2020 May 16. Biol Blood Marrow Transplant. 2020. PMID: 32422253 Free article.
Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation.
Salas MQ, Atenafu EG, Bascom O, Wilson L, Lam W, Law AD, Pasic I, Kim DDH, Michelis FV, Al-Shaibani Z, Gerbitz A, Viswabandya A, Lipton JH, Mattsson J, Alibhai SMH, Kumar R. Salas MQ, et al. Among authors: pasic i. Bone Marrow Transplant. 2021 Jan;56(1):60-69. doi: 10.1038/s41409-020-0979-1. Epub 2020 Jun 30. Bone Marrow Transplant. 2021. PMID: 32606454
83 results